The neurochemistry and pharmacology of extinction behavior - PubMed (original) (raw)
Review
The neurochemistry and pharmacology of extinction behavior
S T Mason. Neurosci Biobehav Rev. 1983 Fall.
Abstract
The role of various neurotransmitter systems in the brain in extinction behavior is examined. An attempt is made to suggest psychological mechanisms (such as attention, secondary reinforcement or internal inhibition) by which the neurotransmitter systems or drugs act to produce the observed alteration in extinction behavior. The putative neurotransmitters acetylcholine, noradrenaline, dopamine, serotonin, endorphins and the peptides are reviewed, as are pharmacological agents such as the benzodiazepines, the barbiturates, the psychodelics, the neuroleptics, the psychomotor stimulants and cannabinoids. Other treatments and factors are considered such as peripheral hormones and the adrenal-pituitary axis. It is suggested that the noradrenergic system may be involved in the expression of extinction behavior by a role in selective attention, the dopamine system via an involvement with secondary reinforcement, the cholinergic system by a mechanism of response inhibition and the barbiturates and benzodiazepines by a block of nonreward.
Similar articles
- The mnemon and its juices: neuromodulation of memory processes.
Gold PE, Zornetzer SF. Gold PE, et al. Behav Neural Biol. 1983 Jul;38(2):151-89. doi: 10.1016/s0163-1047(83)90170-x. Behav Neural Biol. 1983. PMID: 6139106 No abstract available. - [Neuropharmacologic analysis of the process of developing extinctive inhibition in the lobectomized cat].
Shugalev NP. Shugalev NP. Zh Vyssh Nerv Deiat Im I P Pavlova. 1986 Jul-Aug;36(4):652-9. Zh Vyssh Nerv Deiat Im I P Pavlova. 1986. PMID: 2876562 Russian. - The neurochemistry of behavior.
Panksepp J. Panksepp J. Annu Rev Psychol. 1986;37:77-107. doi: 10.1146/annurev.ps.37.020186.000453. Annu Rev Psychol. 1986. PMID: 3963784 No abstract available. - Brain neurotransmitters regulating TRH producing neurons.
Annunziato L, Di Renzo G, Quattrone A, Schettini G, Preziosi P. Annunziato L, et al. Pharmacol Res Commun. 1981 Jan;13(1):1-10. doi: 10.1016/s0031-6989(81)80033-1. Pharmacol Res Commun. 1981. PMID: 6111810 Review. No abstract available. - [Effect of acupuncture on central neurotransmitters].
Xia Y, Cao XD. Xia Y, et al. Zhen Ci Yan Jiu. 1985;10(2):81-91. Zhen Ci Yan Jiu. 1985. PMID: 2868813 Review. Chinese. No abstract available.
Cited by
- Delayed noradrenergic activation in the dorsal hippocampus promotes the long-term persistence of extinguished fear.
Chai N, Liu JF, Xue YX, Yang C, Yan W, Wang HM, Luo YX, Shi HS, Wang JS, Bao YP, Meng SQ, Ding ZB, Wang XY, Lu L. Chai N, et al. Neuropsychopharmacology. 2014 Jul;39(8):1933-45. doi: 10.1038/npp.2014.42. Epub 2014 Feb 19. Neuropsychopharmacology. 2014. PMID: 24553734 Free PMC article. - No evidence for enhanced extinction memory consolidation through noradrenergic reuptake inhibition-delayed memory test and reinstatement in human fMRI.
Lonsdorf TB, Haaker J, Fadai T, Kalisch R. Lonsdorf TB, et al. Psychopharmacology (Berl). 2014 May;231(9):1949-62. doi: 10.1007/s00213-013-3338-8. Epub 2013 Nov 6. Psychopharmacology (Berl). 2014. PMID: 24193372 Clinical Trial. - Opposing catecholamine changes in the bed nucleus of the stria terminalis during intracranial self-stimulation and its extinction.
Park J, Bucher ES, Fontillas K, Owesson-White C, Ariansen JL, Carelli RM, Wightman RM. Park J, et al. Biol Psychiatry. 2013 Jul 1;74(1):69-76. doi: 10.1016/j.biopsych.2012.11.008. Epub 2012 Dec 20. Biol Psychiatry. 2013. PMID: 23260335 Free PMC article. - Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
Morrow SA, Smerbeck A, Patrick K, Cookfair D, Weinstock-Guttman B, Benedict RH. Morrow SA, et al. J Neurol. 2013 Feb;260(2):489-97. doi: 10.1007/s00415-012-6663-7. Epub 2012 Sep 23. J Neurol. 2013. PMID: 23001556 Clinical Trial. - The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial.
Morrow SA, Kaushik T, Zarevics P, Erlanger D, Bear MF, Munschauer FE, Benedict RH. Morrow SA, et al. J Neurol. 2009 Jul;256(7):1095-102. doi: 10.1007/s00415-009-5074-x. Epub 2009 Mar 5. J Neurol. 2009. PMID: 19263186 Clinical Trial.